Correlation Between BioArctic and Stayble Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioArctic and Stayble Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioArctic and Stayble Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioArctic AB and Stayble Therapeutics AB, you can compare the effects of market volatilities on BioArctic and Stayble Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioArctic with a short position of Stayble Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioArctic and Stayble Therapeutics.

Diversification Opportunities for BioArctic and Stayble Therapeutics

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between BioArctic and Stayble is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding BioArctic AB and Stayble Therapeutics AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stayble Therapeutics and BioArctic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioArctic AB are associated (or correlated) with Stayble Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stayble Therapeutics has no effect on the direction of BioArctic i.e., BioArctic and Stayble Therapeutics go up and down completely randomly.

Pair Corralation between BioArctic and Stayble Therapeutics

Assuming the 90 days trading horizon BioArctic AB is expected to under-perform the Stayble Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, BioArctic AB is 2.39 times less risky than Stayble Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Stayble Therapeutics AB is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  415.00  in Stayble Therapeutics AB on September 3, 2024 and sell it today you would lose (358.00) from holding Stayble Therapeutics AB or give up 86.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BioArctic AB  vs.  Stayble Therapeutics AB

 Performance 
       Timeline  
BioArctic AB 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in BioArctic AB are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, BioArctic sustained solid returns over the last few months and may actually be approaching a breakup point.
Stayble Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Stayble Therapeutics AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

BioArctic and Stayble Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioArctic and Stayble Therapeutics

The main advantage of trading using opposite BioArctic and Stayble Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioArctic position performs unexpectedly, Stayble Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stayble Therapeutics will offset losses from the drop in Stayble Therapeutics' long position.
The idea behind BioArctic AB and Stayble Therapeutics AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated